Jude Onyia
Chief Scientific Officer; Director · 9 filings · Latest: Sep 11, 2026
NEUROCRINE BIOSCIENCES INC
Voyager Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NBIX | Jude Onyia | Chief Scientific Officer | Jun 1, 2026 | Sale | $160.25 | 11,000 | $1.8M | 25,846 | |
NBIX | Jude Onyia | Chief Scientific Officer | Jun 1, 2026 | Option Exercise | $84.74 | 11,000 | $932.1K | 36,846 | |
NBIX | JUDE ONYIA | — | Jun 1, 2026 | Proposed Sale | $158.30 | 11,000 | $1.7M | — | |
NBIX | Jude Onyia | Chief Scientific Officer | May 27, 2026 | Sale | $155.53 | 11,000 | $1.7M | 25,846 | |
NBIX | Jude Onyia | Chief Scientific Officer | May 27, 2026 | Option Exercise | $84.74 | 11,000 | $932.1K | 36,846 | |
NBIX | JUDE ONYIA | — | May 27, 2026 | Proposed Sale | $155.73 | 11,000 | $1.7M | — | |
NBIX | Jude Onyia | Chief Scientific Officer | Feb 13, 2026 | Option Exercise | $0.00 | 5,407 | — | 21,066 | |
NBIX | Jude Onyia | Chief Scientific Officer | Feb 12, 2026 | Option Exercise | $0.00 | 2,560 | — | 18,537 | |
NBIX | Jude Onyia | Chief Scientific Officer | Jan 31, 2026 | Option Exercise | $0.00 | 238 | — | 16,119 | |
NBIX | JUDE ONYIA | — | Jul 2, 2025 | Proposed Sale | $128.00 | 80,181 | $10.3M | — | |
NBIX | JUDE ONYIA | — | Feb 13, 2025 | Proposed Sale | $117.18 | 1,447 | $169.6K | — | |
NBIX | JUDE ONYIA | — | Feb 13, 2025 | Proposed Sale | $117.18 | 1,432 | $167.8K | — | |
NBIX | JUDE ONYIA | — | Jan 31, 2025 | Proposed Sale | $153.29 | 126 | $19.3K | — | |
NBIX | JUDE ONYIA | — | Nov 29, 2024 | Proposed Sale | $126.59 | 2,331 | $295.1K | — |